Clinical trial
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
NCT02126449 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- November 30, 2018
- Enrollment
- 131 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, fasting mimicking diet, neoadjuvant chemotherapy, pathological complete response